Ground News

News from pharmafile.com

See all of pharmafile.com news coverage in one place. Discover how pharmafile.com’s media bias informs their coverage and compare with thousands of other news outlets.

Overall, we’ve indexed 150 stories from pharmafile.com over the past 3 months.

Ground News rates pharmafile.com’s media bias as unknown. . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

pharmafile.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about pharmafile.com

Where is pharmafile.com located?pharmafile.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmafile.com News

France Economy · France

Patient-derived xenograft models may become an indispensable tool in precision oncology

100% Center coverage: 1 sources

Cancer remains one of the most pressing global health challenges, with millions of new diagnoses each year. While precision medicine and targeted therapies have transformed treatment strategies, many patients still face drug resistance and disease recurrence.Cancer See the Story

EpiEndo publishes new data supporting glasmacinal’s potential in COPD - Pharmafile

EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of its lead asset, EP395 (glasmacinal), as an oral treatment for chronic obstructive pulmonary disease (COPD). The published data includes findings from both clinical and preclinical studies. A clinical study conducted in collaboration with the Fraunhofer […] The post EpiEndo pub…Read Article

PM Society and CIM launch new leadership programme for pharma marketers - Pharmafile

The Pharmaceutical Marketing (PM) Society has partnered with the Chartered Institute of Marketing (CIM) to launch the PMS & CIM Marketing Leaders Programme – a new initiative aimed at strengthening strategic capability and standards within pharma marketing. The programme will consist of a series of three-day, in-person training sessions delivered by senior CIM course directors […] The post PM Society and CIM launch new leadership programme for p…Pharma Read Article

Digital platform for hypertension management launches in Europe - Pharmafile

Newel Health, a European healthtech company specialising in digital medical devices, has announced that Amicomed, its digital platform for hypertension management, has received CE certification as a class IIa medical device under the European medical device regulation (MDR). This positions Amicomed as a leading digital therapy candidate and, in collaboration with stakeholders, Newel intends to […] The post Digital platform for hypertension manag…Read Article

PL BioScience appoints Oliver Dick as chief technology officer - Pharmafile

PL BioScience, a German life sciences company specialising in the production and development of human platelet lysate (HPL) for cell expansion, has announced the strengthening of its management team with the appointment of Oliver Dick as chief technology officer. This intends to support HPL upscaling in alignment with growing global demand for its animal-free cell […] The post PL BioScience appoints Oliver Dick as chief technology officer appear…Germany · Germany Read Article

PEPperPRINT cLIFT Peptide Microarray Platform

PEPperPRINT has launched its next-generation peptide microarray platform: cLIFT, short for combinatorial Laser-Induced Forward Transfer. Offering a powerful upgrade to the company’s proprietary laser printing platform, the technology is designed to expand peptide printing capabilities and pave the way for innovative biomedical research applications. Peptide microarrays are powerful tools for analysis of antibody or protein–peptide interactions, …Karlsruhe · Karlsruhe See the Story

Meteor Biotech opens site at UCLA to support biotech research - Pharmafile

South Korean spatial omics specialist, Meteor Biotech, has announced the opening of its first international office at the California NanoSystems Institute, University of California, Los Angeles (UCLA). The new site aims to support researchers using Meteor’s spatially-resolved laser-activated cell sorting (SLACS) technology and facilitate the development of new therapies across oncology, immunology and neuroscience. The […] The post Meteor Biotec…UCLA · Los Angeles Read Article

News from pharmafile.com

News from pharmafile.com

Information about pharmafile.com

Media Bias Ratings

Factuality

Ownership

Top pharmafile.com News

Sanofi buys US biopharma group Blueprint in $9.1 bln deal

Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech

Nicotinamide Riboside Shows Promise in Treating Werner Syndrome Symptoms

Fresh Data Bolster TYK2 Blocker for Psoriatic Arthritis

Patient-derived xenograft models may become an indispensable tool in precision oncology

EpiEndo publishes new data supporting glasmacinal’s potential in COPD - Pharmafile

PM Society and CIM launch new leadership programme for pharma marketers - Pharmafile

Digital platform for hypertension management launches in Europe - Pharmafile

PL BioScience appoints Oliver Dick as chief technology officer - Pharmafile

PEPperPRINT cLIFT Peptide Microarray Platform

Meteor Biotech opens site at UCLA to support biotech research - Pharmafile

Similar News Topics

Topics Most Covered by pharmafile.com

Sources Covering Similar Topics

Breaking News Topics Related to pharmafile.com